Prognostic value of vascularity and vascular endothelial growth factor expression in non-small cell lung cancer

Journal of Clinical Pathology

Volumn 54, Issue 2, 2001, Pages 116-120

  Baillie, R ^a   Carlile, J ^a   Pendleton, N ^b   Schor, A M ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Non small cell lung cancer; Prognosis; Vascular endothelial growth factor; Vascularity

Indexed keywords

VASCULOTROPIN; VON WILLEBRAND FACTOR;

ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR CELL; TUMOR VASCULARIZATION;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG; LUNG NEOPLASMS; LYMPHOKINES; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035142923     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.54.2.116     Document Type: Article

References (34)

1. Angiogenesis
2. Role of vascular endothelial growth factor in the regulation of angiogenesis
3. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses turnout growth in vivo
4. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
5. Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer
6. Prognostic value or ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas
7. Bcl2 and p53 regulate vascular endothelial growth factor (VEGF)-mediated angiogenesis in non-small cell lung carcinoma
8. Neoangiogenesis and p53 protein in lung cancer: Their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression
9. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer
10. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer
11. Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma
12. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1) and (VEGF-R2-Flk/KDR) in nonsmall cell lung carcinomas (NSCLC): Correlation with angiogenesis and survival
13. Frequent expression of the vascular endothelial growth factor in human non-small-cell lung cancers
14. High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer
15. Basic fibroblast growth factor and vascular endothelial growth factor in sera from non-small cell lung cancer patients
16. Elevated vascular endothelial growth factor levels in sera of patients with lung cancer
17. Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma
18. Vascular endothelial growth factor and its receptor correlate with angiogenesis and survival in pulmonary adenocarcinoma
19. Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis
20. Angiogenic cytokines in mesothelioma: A study of VEGF, FGF-1 and -2 and TGF beta expression
21. Tumour volume as a predictor of survival after resection of non-small cell lung cancer (NSCLC)
22. Relationship between vascularity, age and survival in non-smallcell lung cancer
23. Assessment of vascularity in histological sections: Effects of methodology and value as an index of angiogenesis in breast tumours
24. Direct method for detection and characterisation of cell surface receptors for insulin by means of 125I-labelled autoantibodies against the insulin receptor
25. Heterogeneity in microvascular density in lung tumours: Comparison with normal bronchus
26. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms
27. Vascular permeability factor/vascular endothelial growth factor and vascular stroma formation in neoplasia: Insights from in situ hybridisation studies
28. Vascular endothelial growth factor and lymph node metastases in primary lung cancer
29. Immunohistochemical study of tumour angiogenesis in oral squamous cell carcinoma
30. Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma
31. Expression of vascular endothelial growth factor in human oral squamous cell carcinoma: Its association with turnout progression and p53 gene status
32. Biological characterization of subgroups of squamous cell lung carcinomas
33. Differential immunolocalisation in rat and human adult lung, and in experimental rat lung fibrosis: Light, fluorescence, and electron microscopy
34. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues macrophages and turnouts